IE40370B1 - Process for preparing injectable compositions - Google Patents

Process for preparing injectable compositions

Info

Publication number
IE40370B1
IE40370B1 IE158/75A IE15875A IE40370B1 IE 40370 B1 IE40370 B1 IE 40370B1 IE 158/75 A IE158/75 A IE 158/75A IE 15875 A IE15875 A IE 15875A IE 40370 B1 IE40370 B1 IE 40370B1
Authority
IE
Ireland
Prior art keywords
allergen
dialdehyde
extract
tyrosine
aqueous solution
Prior art date
Application number
IE158/75A
Other versions
IE40370L (en
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of IE40370L publication Critical patent/IE40370L/en
Publication of IE40370B1 publication Critical patent/IE40370B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/35Allergens
    • A61K39/36Allergens from pollen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

1492973 Modified allergens BEECHAM GROUP Ltd 5 Feb 1975 [16 Feb 1974] 7156/74 Addition to 1377074 Heading A5B Finely divided micro-particles of tyrosine having a water soluble dialdehyde - treated allergen dispersed therein are prepared by mixing an aqueous solution of a water - soluble dialdehyde e.g. glutaraldehyde modified allergenic extract of an allergenic material with a solution of tyrosine in a strong aqueous acid e.g. hydrochloric acid; and simultaneously or subsequently neutralising (i.e. adjusting the pH to from 4 to 7.5) such mixture of solutions thereby precipitating the required product. Sodium hydroxide may be employed to neutralise the reaction mixture. The aqueous solution of modified allergen may be obtained directly by reacting an aqueous solution of an extract of allergenic material with a dialdehyde under neutral conditions. The allergen may be an extract of one or more pollens e.g. grass or ragweed pollen; house dust, the house dust mite Dermatophagoides pteronyssinus, moulds, animal hair, dander or fur. The precipitate of tyrosine containing the dialdehyde treated allergen may be removed from the solution by centrifugation or filtration and washed before being resuspended in a physiologically acceptable carrier such as phenol-saline or sterile water, to produce an injectable composition for use in desensitisation therapy. [GB1492973A]
IE158/75A 1974-02-16 1975-01-27 Process for preparing injectable compositions IE40370B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7156/74A GB1492973A (en) 1974-02-16 1974-02-16 Process for preparing injectable compositions

Publications (2)

Publication Number Publication Date
IE40370L IE40370L (en) 1975-08-16
IE40370B1 true IE40370B1 (en) 1979-05-09

Family

ID=9827690

Family Applications (1)

Application Number Title Priority Date Filing Date
IE158/75A IE40370B1 (en) 1974-02-16 1975-01-27 Process for preparing injectable compositions

Country Status (9)

Country Link
JP (1) JPS5822444B2 (en)
BE (1) BE825579R (en)
DE (1) DE2505814C2 (en)
FR (1) FR2261013B2 (en)
GB (1) GB1492973A (en)
IE (1) IE40370B1 (en)
KE (1) KE3113A (en)
NL (1) NL186295C (en)
ZA (1) ZA75634B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234569A (en) * 1978-10-04 1980-11-18 The Johns Hopkins University Production of aldehyde-treated allergen-containing substances
US5057317A (en) * 1987-03-24 1991-10-15 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
GB9706957D0 (en) * 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
PT1024829E (en) 1997-10-30 2009-03-18 Leti Sl Lab Tolerogenic fragments of natural allergens
GB9820525D0 (en) 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3541201A (en) * 1968-12-18 1970-11-17 Ethan Alan Brown Novel sodium chloride encapsulated injectionable substances
BE754523A (en) * 1969-08-06 1971-02-08 Beecham Group Ltd VACCINES
GB1377074A (en) * 1971-07-13 1974-12-11 Beecham Group Ltd Process for preparing injectable compositions

Also Published As

Publication number Publication date
ZA75634B (en) 1976-01-28
GB1492973A (en) 1977-11-23
BE825579R (en) 1975-08-14
DE2505814A1 (en) 1975-09-18
NL186295B (en) 1990-06-01
FR2261013B2 (en) 1978-07-21
JPS5822444B2 (en) 1983-05-09
NL7501582A (en) 1975-08-19
AU7794375A (en) 1976-08-05
KE3113A (en) 1981-02-20
IE40370L (en) 1975-08-16
DE2505814C2 (en) 1984-11-15
FR2261013A2 (en) 1975-09-12
JPS50116626A (en) 1975-09-12
NL186295C (en) 1990-11-01

Similar Documents

Publication Publication Date Title
US4070455A (en) Process for preparing injectable desensitizing compositions and products thereof in microparticle form
IE36426B1 (en) Process for preparing injectable compositions
IE40370B1 (en) Process for preparing injectable compositions
CH628246A5 (en) METHOD FOR PRODUCING A PROTECTIVE PERTUSSIS ANTIGENT.
DE1768841C3 (en) Covalently bound conjugates of acidic polysaccharides and complex organic substances
DE3834729A1 (en) USE OF ZINC OR IRON HYDROXIDE FOR ADJUVATING ANTIGEN SOLUTIONS AND ANY ADJUSTED ANTIGEN SOLUTIONS THEREFOR
DE2457047A1 (en) DERIVATIVES OF TETANUSTOXIN, PROCESS FOR THEIR PRODUCTION AND PRODUCTS CONTAINING THESE
US3201382A (en) Process for preparing a biochemically active polypeptide from sheep pituitary growthhormone
EP0027664A1 (en) Use of the PP5 protein, its derivatives or the antibodies directed against that protein in contraception or in disruption of pregnancy
US1914824A (en) Process for the preparation of humous colloids
DE19907726A1 (en) Preparation of protein hydrolysates useful in foodstuffs and pharmaceuticals comprises protein homogenization in presence of protease, addition of other proteases and heat inactivation at acidic pH
Kay The reversibility of the action of urease of soy bean
US2555276A (en) Production of amino acids from protein
DE2810855C3 (en) Process for the production of a ferment preparation to accelerate the ripening of meat products
DE2831338C2 (en) Process for the production of a largely heme-free, partially hydrolyzed blood protein product and blood protein product
DE719026C (en) Process for the production of preparations containing the circulatory hormone kallikrein
DE2201518C3 (en) Carrier-bound protein and method for its production - US Pat
SU674990A1 (en) Method of obtaining titanium dioxide
DE3727987A1 (en) PHARMACEUTICAL STRUCTURE
US2166133A (en) Therapeutically valuable gold compounds and a method for producing the same
DE1221643C2 (en) METHOD FOR PRODUCING HUMANHISTAMINE AZO ALBUMINES
GB1240130A (en) Slow-release adsorbed allergens
SU674863A1 (en) Machine tool drive
US1078873A (en) Substance for treatment of tuberculosis and process of making said substance.
SU1660250A1 (en) Method of preparing vestibuloprotecting agent from animal raw